5051 - 5060 of 7785 Results
Title
Year
-
RESTRICTEDTitle: Targeting of the unfolded protein response (UPR) as therapy for Parkinson's diseaseJournal Name: Biology of the CellPublisher: WileyVol: 111Issue #: 6Start Page: 161End Page: 168Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/boc.201800068Citation Count: 36
- A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies2019RESTRICTEDTitle: A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologiesJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 5Start Page: 657End Page: 663Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27671Best OA location URL: https://lirias.kuleuven.be/bitstream/123456789/636637/2/Espay_et_al-2019-Movement_Disorders.pdfCitation Count: 212
-
RESTRICTEDTitle: The Parkinson's disease e‐diary: Developing a clinical and research tool for the digital ageJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 5Start Page: 676End Page: 681Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27673Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114172Citation Count: 48
-
RESTRICTEDTitle: Discovery of Volatile Biomarkers of Parkinson’s Disease from SebumJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 5Issue #: 4Start Page: 599End Page: 606Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acscentsci.8b00879Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acscentsci.8b00879Citation Count: 114
- Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease2019RESTRICTEDTitle: Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's DiseaseJournal Name: Clinical and Translational SciencePublisher: WileyVol: 12Issue #: 3Start Page: 240End Page: 246Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/cts.12619Best OA location URL: https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.12619Citation Count: 15
- Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity2019RESTRICTEDTitle: Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicityJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 939End Page: 960Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-019-01993-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-019-01993-2.pdfCitation Count: 63
- The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease2019RESTRICTEDTitle: The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2019.00057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2019.00057/pdfCitation Count: 19
- DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood2019RESTRICTEDTitle: DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in bloodJournal Name: EpigeneticsPublisher: Informa UK LimitedVol: 14Issue #: 4Start Page: 365End Page: 382Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/15592294.2019.1588682Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15592294.2019.1588682?needAccess=trueCitation Count: 64
- The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT42019RESTRICTEDTitle: The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-40808-yBest OA location URL: https://www.nature.com/articles/s41598-019-40808-y.pdfCitation Count: 23
-
RESTRICTEDTitle: Cholinergic system changes of falls and freezing of gait in Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 4Start Page: 538End Page: 549Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25430Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25430Citation Count: 122